Cargando…
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Osteosarcoma (OS) is a highly prevalent bone malignancy among adolescents, accounting for 40% of all primary malignant bone tumors. Neoadjuvant chemotherapy combined with limb‐preserving surgery has effectively reduced patient disability and mortality, but pulmonary metastases and OS cells' res...
Autores principales: | Ji, Ziyu, Shen, Jianlin, Lan, Yujian, Yi, Qian, Liu, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333890/ https://www.ncbi.nlm.nih.gov/pubmed/37441462 http://dx.doi.org/10.1002/mco2.308 |
Ejemplares similares
-
The role of m6A methylation in osteosarcoma biological processes and its potential clinical value
por: Wu, Yanjiao, et al.
Publicado: (2022) -
Targeting the VEGF Pathway in Osteosarcoma
por: Assi, Tarek, et al.
Publicado: (2021) -
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
por: Shen, Jinze, et al.
Publicado: (2023) -
Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
por: Nirala, Bikesh K., et al.
Publicado: (2023) -
Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
por: Wu, Yujian, et al.
Publicado: (2021)